29 results
424B5
MREO
Mereo Biopharma Group Plc
14 Jun 24
Prospectus supplement for primary offering
4:15pm
favorable results to the plaintiff(s) in any such action.
The deposit agreement governing our ADSs provides that holders and beneficial owners of ADSs … , including results that could be less favorable to the plaintiff(s) in any such action, depending on, among other things, the nature of the claims
S-3
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
if the corporation fails to enforce the right itself. The complaint must:
∎ state that the plaintiff was a stockholder at the time of the transaction of which … the plaintiff complains or that the plaintiffs shares thereafter devolved on the plaintiff by operation of law; and
∎ allege with particularity
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
results to the plaintiff(s) in any such action.
The deposit agreement governing our ADSs provides that holders and beneficial owners of ADSs irrevocably … results that could be less favorable to the plaintiff(s) in any such action, depending on, among other things, the nature of the claims, the judge
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
agrees to be joined as a party plaintiff where necessary under Applicable Law for such initiating Party to initiate and maintain such claim, litigation
F-3/A
gqjdmk 9wc
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
F-3/A
6flrpz 0x
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
bhg2v0poyns9xun
5 Aug 21
Shelf registration (foreign)
4:33pm
F-3
EX-1.2
76v1d82cg
5 Aug 21
Shelf registration (foreign)
4:33pm
424B5
6b6 anaps4
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
lb36ybg9
9 Feb 21
Prospectus supplement for primary offering
5:24pm
424B5
6e7bncqn nc46zvg97a
23 Oct 20
Prospectus supplement for primary offering
4:40pm
F-3
g3a5 s8yh1
6 Oct 20
Shelf registration (foreign)
4:25pm
6-K
EX-10.1
ddzf27y
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am